Evolution of the Average Target: Exor N.V.

Data source: Exor N.V.(EXO)

Evolution of the Target Price: Exor N.V.

Data source: Exor N.V.(EXO)

Changes in Analyst Recommendations: Exor N.V.

Data source: Exor N.V.(EXO)
c404.gwdRfPlXVsMgAx2nmcAeen9e3Cv4BkerRmoTTZMgtKA.zlAiBI0dHoxjUymQqYNUETsRqV2PVAXuFxlbIslux9PsU2VJgzoU8XBSfg~0b51a7f4add316e0f1b77a0d8c943ab0
09-03 AlphaValue/Baader Europe Updates EPS Forecasts for Exor on Expected Dividend Income MT
09-02 Exor: EPS upgrade (2025: +45.4%, 2026: +54.0%) Alphavalue
02-16 AlphaValue/Baader Europe Adjusts Exor Earnings Estimates After Stellantis' Preliminary H2 2025 Results MT
02-13 Exor: EPS cut (2025: -34.6%, 2026: -29.4%) Alphavalue
26/09/25 Exor: Exor H1 2025: Strategy still in waiting Alphavalue
17/09/25 The day the Fed resumed its rate cuts Zonebourse
02/07/25 Exor: Target upgrade by 17.8% Alphavalue
27/03/25 Exor: Exor's strategic moves: Market lagging behind Alphavalue
26/03/25 BNP Paribas Exane Upgrades Exor to Outperform MT
03/12/24 Exor: Adjustments following Exor's reclassification as an Investment Entity Alphavalue
02/12/24 Exor: Stellantis' woes likely to spill over to Exor Alphavalue
02/10/24 KBC Securities Starts Exor at Buy MT
25/09/24 Exor: NAV progresses further Alphavalue
23/07/24 AlphaValue/Baader Europe Upgrades Exor to Buy, Raises PT MT
23/07/24 Exor: Opinion change, from Add to Buy Alphavalue
11/04/24 Exor: Stellantis and Ferrari continue to push Exor forward Alphavalue
05/03/24 Exor: Exor is adept for recovery bets Alphavalue
19/02/24 Exor: NAV cut by -8.8% Alphavalue
01/12/23 Exor : Exor reiterates its faith in Philips Alphavalue
14/09/23 Exor : Exor pushes the throttle Alphavalue
16/08/23 Exor : Exor delivers on its diversification strategy Alphavalue
03/07/23 Exor : EPS upgrade (2022: -20.5%, 2023: +13.5%) Alphavalue
30/05/23 Analysts recommendations: Alliant Energy, Coinbase, Constellation Brands, Medtronic... Zonebourse
17/04/23 Exor : 2022: Another milestone year in Exor's Equity Story Alphavalue
19/01/23 Exor : All eyes on Juventus with Exor and Stellantis potentially impacted Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.84%
-4.12%
+22.45%
+9.26%
+16.34%
+12.85%
+4.96%
+54.17%
+6.18%
Average +16.99%
Weighted average by Cap. +17.25%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
70.70EUR
Average target price
109.00EUR
Spread / Average Target
+54.17%
High Price Target
120.00EUR
Spread / Highest target
+69.73%
Low Price Target
91.00EUR
Spread / Lowest Target
+28.71%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB